INOZYME PHARMA, INC. Operating Lease, Payments
INOZYME PHARMA, INC. reported Operating Lease, Payments of $300.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2025-05-14
- INOZYME PHARMA, INC. operating lease, payments for the quarter ending 2025-03-31 was $300.00K.
- INOZYME PHARMA, INC. operating lease, payments for the quarter ending 2024-12-31 was $200.00K.
- INOZYME PHARMA, INC. operating lease, payments for the quarter ending 2024-09-30 was $300.00K.
- INOZYME PHARMA, INC. operating lease, payments for the quarter ending 2021-12-31 was $200.00K.
- INOZYME PHARMA, INC. operating lease, payments for fiscal 2024 was $1.00M, a 42.86% increase from fiscal 2023.
- INOZYME PHARMA, INC. operating lease, payments for fiscal 2023 was $700.00K, a 22.22% decline from fiscal 2022.
- INOZYME PHARMA, INC. operating lease, payments for fiscal 2022 was $900.00K, a 0.00% change from fiscal 2021.
- INOZYME PHARMA, INC. operating lease, payments for fiscal 2021 was $900.00K, a 50.00% increase from fiscal 2020.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2025-03-31 | $300.00K 10-Q · filed 2025-05-14 | $500.00K derived: sum of 2 quarters · filed 2025-05-14 | $800.00K derived: sum of 3 quarters · filed 2025-05-14 | |
| 2024-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $500.00K derived: sum of 2 quarters · filed 2025-03-10 | $1.00M 10-K · filed 2025-03-10 | |
| 2024-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $800.00K 10-Q · filed 2024-11-05 | ||
| 2024-06-30 | $500.00K 10-Q · filed 2024-08-06 | |||
| 2023-12-31 | $700.00K 10-K · filed 2025-03-10 | |||
| 2022-12-31 | $900.00K 10-K · filed 2023-03-22 | |||
| 2021-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $500.00K derived: sum of 2 quarters · filed 2023-03-22 | $700.00K derived: sum of 3 quarters · filed 2023-03-22 | $900.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $500.00K derived: sum of 2 quarters · filed 2021-11-09 | $700.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $400.00K 10-Q · filed 2021-08-11 | ||
| 2021-03-31 | $200.00K 10-Q · filed 2021-05-12 | |||
| 2020-12-31 | $600.00K 10-K · filed 2022-03-15 |